In ovarian cancer cells, phorbol ester-mediated PKC activation induced phosphorylation of claudins and decreased barrier function [56], and in human epidermal keratinocytes, formation of TJs was suggested to be regulated by a PKC-induced phosphorylation of claudin-4 [57]. This evidence concerns the gene PRRT2 and ovarian cancer.